Dr Reddy’s Laboratories reported Q3 net profit of ₹1,209 crore, beating estimates, while revenue and EBITDA also came in above expectations; though on a year-on-year basis, profit and EBITDA declined and margins contracted sharply, a 4.4% rise in revenue notwithstanding.
